País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
Praziquantel; Fenbendazole
Chanelle Pharmaceuticals Manufacturing Limited
QP52AA51
Praziquantel; Fenbendazole
50, 500 mg/tablet
Tablet
CAM: Companion Animal Medicine as defined in relevant national legislation
Cats, Dogs
praziquantel, combinations
Anthelmintic
Authorised
2005-04-22
SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Quanifen (50mg Praziquantel / 500mg Fenbendazole) Tablets for Cats and Dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION EACH TABLET CONTAINS: ACTIVE SUBSTANCES: Praziquantel 50.0 mg Fenbendazole 500.0 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. A round buff-coloured tablet with a score line. The tablets can be divided into equal quarters. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mixed parasitic infections in dogs and cats caused by roundworms and tapeworms of the following species: Ascarids _Toxocara canis _ (adult) _Toxocara cati_ (adult) _Toxascaris leonina_ (adult) Hookworms _ _ _Uncinaria stenocephala _ (adult) _Ancylostoma caninum _ (adult) Whipworms _Trichuris vulpis _ (adult) Tapeworms _Echinococcus granulosus _ _Echinococcus multilocularis _ _Dipylidium caninum _ _Taenia spp. _ _Mesocestoides spp _ 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substances. Do not use in kittens less than 8 weeks of age. Do not use in pregnant cats. Do not use in pregnant bitches up to day 39 of pregnancy. For further information on treatment of pregnant bitches refer to section 4.7 (Use during pregnancy, lactation or lay) 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Since one of the most common tapeworms of the dog and cat ( _Dipylidium caninum_ ) is transmitted by a flea and has a very short pre-patent period, it is important to pay attention to flea control to reduce the incidence of tapeworm and the risk of re-infection. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable disease in the OIE, specific guidelines on the treatment and follow-up, and on the safeguard of persons, n Leer el documento completo